MX2016003207A - Composiciones que comprenden colina y derivados de esta, usos de las composiciones y procesos para su preparacion. - Google Patents

Composiciones que comprenden colina y derivados de esta, usos de las composiciones y procesos para su preparacion.

Info

Publication number
MX2016003207A
MX2016003207A MX2016003207A MX2016003207A MX2016003207A MX 2016003207 A MX2016003207 A MX 2016003207A MX 2016003207 A MX2016003207 A MX 2016003207A MX 2016003207 A MX2016003207 A MX 2016003207A MX 2016003207 A MX2016003207 A MX 2016003207A
Authority
MX
Mexico
Prior art keywords
choline
processes
preparation
derivatives
compositions
Prior art date
Application number
MX2016003207A
Other languages
English (en)
Inventor
WEIDBERG Asher
NUMA Ran
Ben-Dror Gai
Bar-Yoseph Fabiana
Original Assignee
Enzymotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enzymotec Ltd filed Critical Enzymotec Ltd
Publication of MX2016003207A publication Critical patent/MX2016003207A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pediatric Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invención proporciona composiciones que comprenden colina y derivados solubles en agua de estas, procesos para su preparación a partir de fuentes naturales y usos de estas.
MX2016003207A 2013-10-21 2014-10-21 Composiciones que comprenden colina y derivados de esta, usos de las composiciones y procesos para su preparacion. MX2016003207A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361893308P 2013-10-21 2013-10-21
US201361893307P 2013-10-21 2013-10-21
PCT/IL2014/050912 WO2015059697A1 (en) 2013-10-21 2014-10-21 Compositions comprising choline and derivatives thereof, uses thereof and processes for their preparation

Publications (1)

Publication Number Publication Date
MX2016003207A true MX2016003207A (es) 2016-08-11

Family

ID=51999472

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016003207A MX2016003207A (es) 2013-10-21 2014-10-21 Composiciones que comprenden colina y derivados de esta, usos de las composiciones y procesos para su preparacion.

Country Status (11)

Country Link
US (1) US20160243061A1 (es)
EP (1) EP3060202A1 (es)
JP (1) JP2016535734A (es)
KR (1) KR20160075524A (es)
CN (1) CN105682481A (es)
AU (1) AU2014338503A1 (es)
HK (1) HK1222336A1 (es)
IL (1) IL244484A0 (es)
MX (1) MX2016003207A (es)
SG (1) SG11201602066RA (es)
WO (1) WO2015059697A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180228819A1 (en) * 2015-04-21 2018-08-16 Enzymotec Ltd. Compositions comprising choline and derivatives thereof, uses thereof and processes for their preparation
CN108813628A (zh) * 2018-05-23 2018-11-16 青岛大学 一种防治帕金森病食用组合物的制备方法
CN108813453A (zh) * 2018-05-23 2018-11-16 青岛大学 一种防治帕金森病的食用组合物
US20210212936A1 (en) * 2018-06-01 2021-07-15 Baxter International Inc. Parenteral nutrition formulation

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2864848A (en) 1954-07-19 1958-12-16 Ca Nat Research Council Method of producing l-alpha-glycerylphosphorylcholine
US3475177A (en) * 1966-02-09 1969-10-28 Commercial Solvents Corp Choline composition
JPS62111926A (ja) * 1985-11-11 1987-05-22 Nippon Oil & Fats Co Ltd コリン作働性神経系活性化剤
JPH0656671A (ja) * 1992-08-04 1994-03-01 Nippon Oil & Fats Co Ltd 機能性食品
CN1115217A (zh) * 1994-07-22 1996-01-24 戴根春 鸡蛋保健品的制造方法
US6013273A (en) * 1997-01-27 2000-01-11 Novartis Nutrition Ag Treatment of endotoxic shock
US20040043013A1 (en) * 2000-12-28 2004-03-04 Mccleary Edward Larry Metabolic uncoupling therapy
US20030206881A1 (en) * 2001-05-31 2003-11-06 Peter Fussbroich Phospholipidic composition as well as the use thereof
EP1643863A2 (en) * 2003-07-10 2006-04-12 Carl A. Forest Foods, beverages, condiments, spices and salad dressings with specialized supplements
WO2007010892A1 (ja) 2005-07-19 2007-01-25 Asahi Kasei Pharma Corporation 新規なリン脂質加工剤
JP5300186B2 (ja) * 2006-08-23 2013-09-25 株式会社明治 血中ホモシステイン濃度の上昇を抑制する妊婦用の乳由来組成物
WO2008127358A2 (en) * 2006-10-10 2008-10-23 Jina Pharmaceuticals, Inc. Aqueous systems for the preparation of lipid-based pharmaceutical compounds; compositions, methods, and uses thereof
WO2008067640A1 (en) * 2006-12-06 2008-06-12 H3 Formulations Ltd. Composition for promoting cognitive attributes
JP2009155337A (ja) * 2009-03-31 2009-07-16 Tsujido Chemical Corp 治療剤
CN102802442B (zh) * 2009-06-16 2014-05-07 株式会社明治 防止新生儿出生体重降低的风险的孕妇用来自牛乳的组合物
KR101522123B1 (ko) * 2010-12-29 2015-05-20 니시자키 바이오인포메이션 리서치 인스티튜트 인지 기능 개선을 위한 병용제
ITGE20110050A1 (it) * 2011-04-29 2012-10-30 Marco Zipoli Alimento, in particolare una bevanda per l'alimentazione umana
CN102516292B (zh) * 2011-11-08 2014-09-10 西北大学 一种天然L-α-甘油磷脂酰胆碱及其制备方法
CN102964377B (zh) * 2012-11-30 2015-05-27 西北大学 一种天然L-α-甘油磷脂酰胆碱的制备方法
EP2859889A1 (en) * 2013-10-14 2015-04-15 Abbott Laboratories Compositions and methods for improving cognitive function

Also Published As

Publication number Publication date
AU2014338503A1 (en) 2016-03-31
SG11201602066RA (en) 2016-04-28
IL244484A0 (en) 2016-04-21
CN105682481A (zh) 2016-06-15
WO2015059697A1 (en) 2015-04-30
HK1222336A1 (zh) 2017-06-30
JP2016535734A (ja) 2016-11-17
EP3060202A1 (en) 2016-08-31
KR20160075524A (ko) 2016-06-29
US20160243061A1 (en) 2016-08-25

Similar Documents

Publication Publication Date Title
PH12016501763A1 (en) Multispecific antibodies
MX2023008693A (es) Polinucleotidos moduladores.
MX2022016566A (es) Composiciones que comprenden una caseina y metodos para producir las mismas.
PH12016502586A1 (en) Lipid comprising docosapentaenoic acid
MX2022015755A (es) Profarmacos de hormona paratiroidea (pth).
MX2016003843A (es) Inhibidores de cinasas asociadas al receptor de interleucina 1 (irak) y usos de los mismos.
MX2015008999A (es) Inhibidores mk2 y usos de los mismos.
MX2016016143A (es) Compuestos de [1,2,4]triazol sustituido.
SG10201902326XA (en) Mk2 inhibitors and uses thereof
MX2017009720A (es) Composiciones de oligosacaridos para el uso en composiciones nutricionales y metodos para producirlas.
MX2016009590A (es) Composiciones de apilimod y métodos para usar las mismas.
MX2018000715A (es) Metodos para tratar cancer usando apilimod.
MX2017008390A (es) Uretanos funcionalizados con alcoxisilano y funcionalizados con alofanato.
MX2017008414A (es) Composiciones inhibidoras de nitrificacion y metodos para preparar las mismas.
EP3391320A4 (en) DOCUMENT GENERATION SYSTEM FOR ACCOMPANIMENT DOCUMENTS FOR DIRECT PUBLICATION
SG10201900598TA (en) Factor viii formulation
MX371128B (es) Compuestos de dihidropirimidin-2-ona y su uso medico.
IN2014CH00840A (es)
AU2016361427A8 (en) Platinum anticancer agents
MX2015013021A (es) 5-bromo-indirrubinas.
IN2014CH00151A (es)
MX2016003207A (es) Composiciones que comprenden colina y derivados de esta, usos de las composiciones y procesos para su preparacion.
MX2015016603A (es) Composiciones de corticosteroides.
MX2017010526A (es) Mezclas de aceite, procesos para la preparacion de estas y su uso en formulas.
NZ721832A (en) Solid forms of tenofovir